This is the authors' abstract. We don't add key points for this paper.
PAK4, a serine threonine kinase, has been identified as a potential target in several tumors and its prominence in PDAC suggests it could present an exciting therapeutic opportunity.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Thillai et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: